Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2022-05-04
2024-04-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Time-restricted Eating in Survivors Trial
NCT05639829
Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants
NCT03546972
Effect of Time-Restricted Feeding on Fat Loss and Cardiometabolic Risk Factors in Overweight Adults
NCT03459703
Time Restricted Diet in Obese or Overweight Pre or Postmenopausal Participants
NCT02154984
Time-Restricted Eating to Address Persistent Cancer-Related Fatigue
NCT05256888
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Time restricted feeding
daily eating period of 8 hours, before 8 PM for 12 weeks
Time restricted feeding
Participants will eat all food during a self selected 8 hour eating window prior to 8:00 PM.
Control
daily eating period ≥ 12 hours for 12 weeks
Control
Participants will have a daily eating period equal to or greater than 12 hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Time restricted feeding
Participants will eat all food during a self selected 8 hour eating window prior to 8:00 PM.
Control
Participants will have a daily eating period equal to or greater than 12 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Postmenopausal women (no menstrual periods in the preceding 12 or more months) with pre-diabetes (A1C 5.7-6.4% and/or fasting glucose 100-125 mg/dL). A1c lab and/or fasting glucose criteria will need to be met within 12 months of signing consent form, can be obtained from prior lab result or study prescreening testing;
* Own a smart phone with internet connection and capable of receiving and sending text messages and taking photographs;
Exclusion Criteria
* Active malignancy or history of cancer;
* History of known liver disease (by serology: aspartate aminotransferase or alanine aminotransferase ≥ 3 times above upper limit of normal determined by lab review, imaging or biopsy: determined by patient history);
* History of kidney disease (patient history and/or estimated glomerular filtration rate less than 45 mL/min/1.73m²);
* History of diabetes mellitus:
* History of cardiovascular disease (MI, CHF);
* Current prescription medication use for diabetes;
* Medication affecting glucose metabolism or appetite or immunosuppression;
* Dietary restrictions: currently following vegetarian or vegan dietary pattern;
* Currently following intermittent fasting or time restricted feeding pattern or use in the last 3 months;
* Night shift worker (work schedule does not involve any period of work from 10 PM to 5 AM either on a regular or rotating basis);
* History of weight loss \>5% in the last 3 months;
* History of weight loss surgery.
* BMI≥40 kg/m² exclusion;
* After informed consent and run in period: Insufficient documented food photography/annotated entries (does not log at least two entries a day for 10 of 14 days) during run in period will be excluded from randomization in to the intervention period.
40 Years
67 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Harsha Karanchi, MD
Role: PRINCIPAL_INVESTIGATOR
Medical University of South Carolina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of South Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
109489
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.